Highly frequent and enhanced injection site reaction induced by peripheral venous injection of fosaprepitant in anthracycline-treated patients
about
Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectivesAprepitant and fosaprepitant drug interactions: a systematic review.Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.Benefits and Risks of Fosaprepitant in Patients Receiving Emetogenic Regimens.Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs.In Vitro L6 Irritation Assay Predicts Clinical Injection Site Reactions for Small Molecules.Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation.Safety of Polysorbate 80 in the Oncology Setting.
P2860
Q26744323-966B6D64-B34E-4C54-9753-FE1E3F322D0BQ39282847-7A06992C-6352-4A42-9E39-3A8F7709F094Q39653943-90233C1D-5F3C-4D80-995C-E95708B4869BQ41016050-8BDF2E11-D6BD-4EAE-A5D2-2644D0178C6EQ50165357-A2AE0222-962C-4CB9-AECC-A484813F4407Q52881046-6EFA2941-07A2-4949-B3E9-EE4B0816652CQ53837638-61298DDA-2757-4508-94AA-5E4C7C71ABA0Q55405018-D0BEF0B6-A171-4EF5-BC2C-317669D9EFB7
P2860
Highly frequent and enhanced injection site reaction induced by peripheral venous injection of fosaprepitant in anthracycline-treated patients
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Highly frequent and enhanced i ...... anthracycline-treated patients
@ast
Highly frequent and enhanced i ...... anthracycline-treated patients
@en
Highly frequent and enhanced i ...... nthracycline-treated patients.
@nl
type
label
Highly frequent and enhanced i ...... anthracycline-treated patients
@ast
Highly frequent and enhanced i ...... anthracycline-treated patients
@en
Highly frequent and enhanced i ...... nthracycline-treated patients.
@nl
prefLabel
Highly frequent and enhanced i ...... anthracycline-treated patients
@ast
Highly frequent and enhanced i ...... anthracycline-treated patients
@en
Highly frequent and enhanced i ...... nthracycline-treated patients.
@nl
P2093
P2860
P356
P1433
P1476
Highly frequent and enhanced i ...... anthracycline-treated patients
@en
P2093
Atsushi Inagaki
Atsushi Wakita
Chika Okada
Hiroka Ogura
Hirokazu Komatsu
Hiroo Sawada
Hiroshi Sugiura
Junko Kuroda
Kazunori Kimura
Koichi Yamada
P2860
P304
P356
10.7150/JCA.7706
P577
2014-04-24T00:00:00Z